Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022
Wed, March 16, 2022
Tue, March 15, 2022
Mon, March 14, 2022
Fri, March 11, 2022

Vamil Divan Maintained (XERS) at Strong Buy with Decreased Target to $6 on, Mar 16th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-6-on-mar-16th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Vamil Divan of Mizuho, Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy with Decreased Target from $8 to $6 on, Mar 16th, 2022.

Vamil has made no other calls on XERS in the last 4 months.



There are 2 other peers that have a rating on XERS. Out of the 2 peers that are also analyzing XERS, 0 agree with Vamil's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vamil


  • Roanna Ruiz of "SVB Leerink" Maintained at Buy with Decreased Target to $6 on, Wednesday, February 16th, 2022
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $5.4 on, Friday, December 31st, 2021